•  

    Fall 2026 Application

    Digital Innovations in 
    Immunology

  • Overview and Instructions

    Thank you for your interest in participating in PharmStars’ upcoming accelerator program. Please follow these guidelines:

    • Browser: We recommend using a Chrome browser to complete this application and disabling pop-up blockers to avoid issues when submitting the application.
    • Data: Do not include any confidential information, patient data, or links to patient data.
    • Drafts cannot be saved: This application cannot be saved as a draft. You may download a copy of the application here to work on the application offline.
    • Submission
      • Submission must be done online. Written copies are not accepted.
      • All mandatory fields, indicated with an asterisk, must be filled in to submit the application.
      • The application cannot be edited after submission.
      • A copy of your application will be sent to you upon successful submission.

    Applications must be submitted by 11:59 p.m. ET on July 12, 2026 to be considered.

     

  • Demographics

  • Will you be one of the two main participants representing your startup in the program?

  • Solution

  • 1. What is the status of your solution?*
  • 1a. What remains to be done to get your concept/prototype ready for market?*
  • 1b. When will your product be ready for market?*
     - -
    2 digit month, 2 digit day, 4 digit year
  • 2. What is your solution? (check all that apply)*
  • 3. What type of technology do you have? (check all that apply)*
  • 4. What is the problem you are trying to solve?*

  • Maximum 1000 characters

  • 5. What is your solution? Who is the primary user and how do they use your solution? Note: please describe your solution from a "technical" rather than a "sales" perspective. We want to understand clearly what your solution is and how it works.*
  • 6. What problem within immunology does your solution address? How does it solve this problem?*

  • Maximum 1000 characters

  • 7. What is your business model? How and to whom do you sell your solution?*

  • Maximum 1000 characters

  • 8. Has your solution been used by pharma? If so, how and where?*

  • Maximum 1000 characters

  • 9. Please describe actual business use cases where your product has been used.*

  • Maximum 1000 characters

  • 10. Are others (providers, payers) using your solution?*
  • 10a. How are others (providers, payers) using your solution?*

  • Maximum 1000 characters

  • 14. Is your solution regulated?*
  • 14a. What is your regulatory status?*
  • 14b. What is your regulatory strategy?*

  • Company Details

  • 15. Have you raised funding for this company?*
  • 15b. How much did your company raise in its last round? (please provide total in US dollars)*
  • 15c. How much has your company raised in total? (please provide total in US dollars)*
  • 16. When will you be raising funds next?*
  • 17. Do you have revenues?*
  • 17a. What is your annual revenue? (please provide total in US dollars)*
  • 20. When was your company founded? *
     - -
    2 digit month, 2 digit day, 4 digit year

  • Experience

  • 22. Is your startup currently negotiating or working with any pharma firms, or has your startup negotiated or worked with pharma in the past?*
  • 22a. Which firms are you working with and on what?*

  • Maximum 1000 characters

  • 22b. Please indicate the level of engagement you have had with each of the following pharmaceutical companies, including the date of your last engagement or contact with each one. (check all that apply)*
    Rows
  • 22b. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Alexion?*
  • 22b-i. Please check all that apply and indicate the date of last engagement or contact with Alexion.*
  • 22b-ii. What is the date of your last engagement or contact with Alexion?*
  • 22c. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with AstraZeneca?*
  • 22c-i. Please check all that apply and indicate the date of last engagement or contact with AstraZeneca.*
  • 22c-ii. What is the date of your last engagement or contact with AstraZeneca?*
  • 22d. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with CSL?*
  • 22d-i. Please check all that apply and indicate the date of last engagement or contact with CSL.*
  • 22d-ii. What is the date of your last engagement or contact with CSL?*
  • 22e. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Genmab?*
  • 22e-i. Please check all that apply and indicate the date of last engagement or contact with Genmab.*
  • 22e-ii. What is the date of your last engagement or contact with Genmab?*
  • 22f. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Jazz?*
  • 22f-i. Please check all that apply and indicate the date of last engagement or contact with Jazz.*
  • 22f-ii. What is the date of your last engagement or contact with Jazz?*
  • 22g. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Novartis?*
  • 22g-i. Please check all that apply and indicate the date of last engagement or contact with Novartis.*
  • 22g-ii. What is the date of your last engagement or contact with Novartis?*
  • 22h. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Pfizer?*
  • 22h-i. Please check all that apply and indicate the date of last engagement or contact with Pfizer.*
  • 22h-ii. What is the date of your last engagement or contact with Pfizer?*
  • 22j. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Sanofi?*
  • 22j-i. Please check all that apply and indicate the date of last engagement or contact with Sanofi.*
  • 22j-ii. What is the date of your last engagement or contact with Sanofi?*
  • 22i. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Sumitomo?*
  • 22i-i. Please check all that apply and indicate the date of last engagement or contact with Sumitomo.*
  • 22i-ii. What is the date of your last engagement or contact with Sumitomo?*
  • 22j. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Takeda?*
  • 22j-i. Please check all that apply and indicate the date of last engagement or contact with Takeda.*
  • 22j-ii. What is the date of your last engagement or contact with Takeda?*
  • 22c. If you are unable to disclose engagements with any pharma companies, how many from this list of our members have you worked with or are you working with currently?

  • Maximum 1000 characters

  • 22d. What has been your experience working with pharma thus far?*

  • Maximum 1000 characters

  • Accelerator Participation

  • 23. What are your goals for participating in the PharmStars accelerator?*

  • Maximum 1000 characters

  • 24. Have you participated in any other accelerators?*

  • 25. Who will represent your company in PharmaU? (Please note: PharmStars expects participation by the CEO and at least one additional full-time senior-level executives with decision-making authority.)

    Representative 1 (required) - CEO:
             
                        
                     

  • Is the CEO full time with this company?*
  • Is the CEO involved with any other company?*

  • Representative 2 (required):
              
           
            

    Representative 3 (optional): 
              
           
                          

    Representative 4 (optional): 
                
                 
                                                                      

  • 26. Are all the people listed above full-time and permanent employees of your organization?*
  • 27. Are all the people listed above aware this application is being submitted and available to participate in PharmStars as described in the Accelerator Terms?*

  • 28.  You must be 18 years or older to participate in PharmStars. Please confirm both representatives are eligible to participate in the program:

  • 29. If selected, will both of the primary representatives of your startup attend the in-person launch event in Boston, MA on September 9-10, barring special circumstances that would prevent you from doing so (illness, travel restrictions, etc.)?*
  • 30. How did you hear about PharmStars?*
  • 31. Would you like to sign up for our newsletter to get practical tips on engaging with pharma and stay informed about upcoming PharmStars programs?

  • Additional Information

  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • Anything else you would like to share?

  • Maximum 1000 characters

  • The Submission Process

    Please confirm that you have read and will comply with the Accelerator Terms if selected to participate in PharmStars.  

  • Please review the following information and guidelines carefully:

    • Deadline:
      • Your application must be submitted by 11:59 p.m. ET on July 12 to be considered. 
    • Notifications:
      • Semi-finalists will be notified on a rolling basis and will have 3 business days to confirm their continued participation in the application process.
      • Accelerator acceptances will be emailed no later than August 26. Startups will have 2 business days to confirm their acceptance.
    • Launch Event:
      • PharmStars Fall cohort commences with a mandatory, in-person kickoff on September 9-10 in Boston, MA.
      • Please hold these dates to ensure attendance should your startup be selected to participate.
    • Class Schedule:
      • Classes meet virtually every Monday and Thursday from 12-1:30 p.m. ET, September 14 - November 5.
      • Please mark your calendar and ensure that you are available to attend all the twice-weekly classes.

  • Upon successful submission of your application:

    • Survey Page: You will be redirected to a survey page. If you are not redirected to the survey, please check your form for errors.
    • Email Confirmation: You should receive email confirmation of our receipt of your application within one hour. Please contact us at info@PharmStars.com if you do not receive a confirmation.
    • Copy of Your Submission: The confirmation email will include a copy of your submission. We highly recommend you save the PDF of your submission as you will need it as you advance through the process.

  • Thank you for applying to PharmStars!

  • Please contact info@PharmStars.com for questions.

  • Should be Empty: